by publisher – Page 8 – Retraction Watch

A journal editor once told us authors were free to publish ‘bullshit and fiction.’ Apparently his publisher disagrees.

A journal editor who disdains anonymous concerns about research integrity has just seen an article in his journal retracted, thanks to the work of a pseudonymous sleuth.

The paper at issue, “An experimental investigation into the effects of Cr2O3 and ZnO2 nanoparticles on the mechanical properties and durability of self-compacting mortar,” was published in 2015 in International Journal of Materials Research (IJMR). It has been cited 23 times, according to Clarivate’s Web of Science.

In 2020, the pseudonymous sleuth Artemisia Stricta first alerted IJMR leadership to possible image manipulation in the article as part of an extensive report on hundreds of compromised papers. Editors and the journal’s publisher De Gruyter did not investigate the case for two years.

During that time, Guido Schmitz of the University of Stuttgart became the journal’s editor in chief. When Artemisia followed up on their report, Schmitz said that he would not investigate the potential misconduct until Artemisia revealed their identity:

When journals don’t meet their ethical guidelines, will anyone hold them accountable?

Public attention to the use of animals in research is on the rise, and with good reason. As scientists, we have a responsibility to avoid using animals in our work whenever possible. Not only does this prevent needless suffering and waste of resources, it also leads to better science, because findings from animal experiments often fail to hold up in humans. If studies can be conducted ethically with human subjects, tissues, or organs, they should not use animals.

On paper, some journals appear to clear this bar. In reality, however, they fall short of carrying out their ethical responsibility: We see many examples, especially in journals in the nutrition field, of published research that was conducted in animals but could have been carried out in humans or using human-relevant methods.

For example, a recent study fed monkeys Western- and Mediterranean-style diets to produce information about the diets’ effects on human mood and behavior. Another experiment used pigs to evaluate how diets rich in fruits and vegetables can improve human microbiome health.

This should give pause to the National Library of Medicine (NLM). When deciding if a journal merits inclusion in MEDLINE, the leading bibliographic database for life sciences, NLM may look at whether the journal’s ethical policies align with best practices and how well individual articles adhere to those policies.

When it takes two university-federal agency letters – and five years – for a journal to retract a paper

In June of 2020, officials from the Veterans Affairs Medical Center of San Francisco and the University of California, San Francisco, sent a letter to the journal Oncogene with the findings of an investigation of scientific misconduct: A paper the journal had published in 2007 contained “falsified data,” and the officials recommended the journal “assess this paper for retraction.”

The 2020 letter – which we obtained through a public records request – was the second time the institutions had alerted the journal. As the officials stated, a previous investigation had found issues in the 2007 paper, and UCSF-VA had communicated “earlier evidence that this same paper had data fabrication and/or falsification constituting research misconduct” to the journal in 2017.

“Even though the journal has been notified after the last investigation and not taken action,” the 2020 letter stated, “they should be notified again because additional research misconduct has been found.”

In fact, a journal staffer was in the midst of discussing the issues in the article with Rajivir Dahiya, the corresponding author and then director of UCSF’s Urology Research Center with an appointment at the San Francisco VA Medical Center, according to emails seen by Retraction Watch.

Here’s one article that won’t be making any top 50 papers list

Who doesn’t love a list? The 500 best rock songs of all time. The 100 tallest buildings on the planet. The 10 smartest dog breeds. The 14 silliest place-names on earth (with Middelfart, Denmark in the six-spot, you can only imagine the places you’ll go.)

In October, the Arthroscopy, Sports Medicine, and Rehabilitation tried – and failed – to publish its own ranking of important papers in the field. The article, “The Top 50 Articles on Knee Posterolateral Corner Injuries,” by a group at Tulane University in New Orleans, purported to give readers a run-down of the 50 most-cited papers on posterolateral corner injuries between 1976 and 2021.

If you’re afraid of numbers, you might want to skip ahead. If not: Within the top 50 was a Top 10 list, capped by this 2009 review article, which, according to the authors, had garnered 205 citations – and amassed a citation density of 15.77 (citations divided by years in print) – since publication.

Citation density, meet the dust. According to the retraction notice:

After a sleuth reveals a paper with authorships advertised for sale, it’s retracted

Last August 12th, Nick Wise came across a Facebook post advertising the first, third, and fifth author positions for sale on a scientific paper with the same title as a recently published article.

Wise, a scientific sleuth whose work has resulted in more than 850 retractions, posted a comment on PubPeer with a screenshot of the advertisement and contacted the publisher of the journal.

Six months later, the article, “Potential application of AlP nanosheet semiconductor in the detection of toxic phosgene, thiophosgene, and formaldehyde gases,” has been retracted. It had appeared in Semiconductor Science and Technology, an IOP Publishing title, and has been cited once.

Meanwhile, the authorship broker says he has left the business.

Wiley paused Hindawi special issues amid quality problems, lost $9 million in revenue

Hindawi, the open access publisher that Wiley acquired in 2021, temporarily suspended publishing special issues because of “compromised articles,” according to a press release announcing the company’s third quarter financial results.

Brian Napack, Wiley’s president and CEO, specifically noted the “unplanned publishing pause at Hindawi” as a factor that “challenged” the company this year.

The pause began in mid-October and ended in mid-January, a Wiley spokesperson told us.

In Wiley’s third quarter that ended Jan. 31, 2023, the suspension cost Hindawi – whose business model is based on charging authors to publish – $9 million in lost revenue compared to the third quarter of 2022. The company cited the pause as the primary reason its revenue from its research segment “was down 4% as reported, or down 2% at constant currency and excluding acquisitions,” the press release stated.

Two years ago, an author asked a journal to withdraw a paper. It still hasn’t.

In November of 2020, an economics professor wrote to the editor-in-chief of a journal with two requests: remove his name from an online paper on which he was the corresponding author, and retract the article.

More than two years later, neither of those things has happened.

Instead, the article, “Outward foreign direct investment and economic growth in Romania: Evidence from non-linear ARDL approach,” which appeared in August 2020 in the International Journal of Finance and Economics, was included in the January 2022 issue of the journal. It has been cited 10 times, according to Clarivate’s Web of Science.

A scholar who was involved in the work but left off the paper has provided evidence, seen by Retraction Watch, that the published article contains falsified data. Two of the paper’s authors also have had another article they co-authored together retracted.

The Whack-a-Mole problem: Hijacked journal still being indexed in Scopus even after discovery

Have you heard about hijacked journals, which take over legitimate publications’ titles, ISSNs, and other metadata without their permission? We recently launched the Retraction Watch Hijacked Journal Checker, and will be publishing regular posts like this one to tell the stories of some of those cases.

Hijacked journal: Linguistica Antverpiensia, New Series – Themes in Translation Studies

What happened: The journal became a perfect target for hijackers when it expanded its title from “Linguistica Antverpiensia” and changed its web domain.

Fraudulent publishers hijacked the journal in 2021, re-registering the old, expired domain under the original, shorter name Linguistica Antverpiensia.

Springer Nature retracts chapter on sign language deaf scholars called “extremely offensive”

Springer Nature has retracted a book chapter which critics say was plagued with “extremely offensive and outdated” statements about the deaf community.

The chapter, “Literature Review on Sign Language Generation,” was published in September 2022 as part of Data Management, Analytics and Innovation: Proceedings of ICDMAI 2022 (International Conference on Data Management, Analytics and Innovation). The authors, five researchers at the Cummins College of Engineering for Women in Pune, India, attempted to review work on sign language translation – specifically with artificial intelligence and machine learning.

From the abstract:

Ob-gyn who called criticism ‘racist’ and ‘hate speech’ earns retraction, several expressions of concern

There shouldn’t have been many differences between the women recruited for the three clinical trials: All of them gave birth at the same two Cairo hospitals over a period of less than three years, and all of them were treated to prevent or manage postpartum bleeding. Three samples from this pool of patients, Ben Mol felt, should have had largely similar baseline characteristics.

Yet, mysteriously, the women’s mean age and BMI varied markedly across the studies—from 25 to 34 years and from 25 to 29 kg/m2, respectively—as did the birthweight of their babies.

So the researcher turned data sleuth began digging. His worries only grew. Eventually, he would come to question the integrity of nearly two dozen randomized controlled trials led by Ahmed Maged, a professor of obstetrics and gynecology at Egypt’s top medical school, Kasr AlAiny at Cairo University.

Now, based in part on Mol’s findings, two journals published by Taylor & Francis have issued a retraction and nine expressions of concern for the following papers:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: